Prognostic factors of liver metastases from uveal melanoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 10, 2005, Pages 985-993

  Kodjikian, Laurent ^a,b   Grange, Jean Daniel ^a   Baldo, Stéphano ^c   Baillif, Stéphanie ^a   Garweg, Justus G ^b   Rivoire, Michel ^c  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITY OF BERN   (Switzerland)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

Liver metastasis; Prognostic factors; Surgical treatment; Uveal melanoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; FOTEMUSTINE; INTERFERON; INTERLEUKIN 2; VINBLASTINE;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CILIARY BODY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DEMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CARE; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL TIME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 27744602715     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-1188-8     Document Type: Article

References (34)

1. Aoyama T, Mastrangelo MJ, Berd D, Nathan FE, Shields CL, Shields JA, Rosato EL, Rosato FE, Sato T (2000) Protracted survival after resection of metastatic uveal melanoma. Cancer 89:1561-1568 10.1002/ 1097-0142(20001001)89:7<1561::AID-CNCR21>3.0.CO;2-R
2. Bedikian AY, Kantarjian H, Young SE, Bodey GP (1981) Prognosis in metastatic choroidal melanoma. South Med J 74:574-577 7244714
3. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS (1995) Treatment of uveal melanoma metastatic to the liver: A review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 76:1665-1670 8635073
4. Cox D (1972) Regression models and life-tables (with discussions). J R Statist Soc Series B 34:187-220
5. Eskelin S, Pyrhonen S, Hahka-Kemppinem M, Tuomaala S, Kivela T (2003) A prognostic model and staging for metastatic uveal melanoma. Cancer 97:465-475 10.1002/cncr.11113
6. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD (1991) Survival of patients with metastases from uveal melanoma. Ophthalmology 98:383-389; discussion 90 2023760
7. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A (1988) Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology 95 992-999 2845324
8. Gragoudas ES, Seddon JM, Egan KM, Polivogianis L, Hsieh CC, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M et al (1986) Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology 93:675-680 3014416
9. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481
10. Karakousis CP, Temple DF, Moore R, Ambrus JL (1983) Prognostic parameters in recurrent malignant melanoma. Cancer 52:575-579 6861095
11. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hoffken K, Seeber S (1993) Prognosis and treatment of disseminated uveal melanoma. Cancer 72:2219-2223 7848381
12. Kodjikian L, Roy P, Rouberol F, Chauvel P, Jean-Louis B, Garweg J, Little R, Sasco A, Grange J (2004) Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol 137:1002-1010 10.1016/ j.ajo.2004.01.006
13. Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L (1997) Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15:2589-2595 9215829
14. Li W, Gragoudas ES, Egan KM (2000) Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol 118:1066-1070 10922199
15. McLean IW, Foster WD, Zimmerman LE (1982) Uveal melanoma: Location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 13:123-132 7076200
16. McLean IW, Foster WD, Zimmerman LE (1977) Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophtalmol 95:48-58
17. Oken M, Creech R, Tormey D (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655 7165009
18. Patel JK, Didolkar MS, Pickren JW, Moore RH (1978) Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135:807-810 10.1016/0002-9610(78)90171-X
19. Peto R, Peto J (1972) Asymptotically efficient rank invariant test procedures. J R Statist Soc Series A 135:185-206
20. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347:1222-1225 10.1016/S0140-6736(96)90736-9
21. Pyrhonen S (1998) The treatment of metastatic uveal melanoma. Eur J Cancer 34(Suppl 3):S27-S30 10.1016/S0959-8049(97)10161-7
22. Raivio I (1977) Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl 133:1-64 196476
23. Rajpal S, Moore R, Karakousis CP (1983) Survival in metastatic ocular melanoma. Cancer 52:334-336 6190546
24. Rouberol F, Roy P, Kodjikian L, Gérard J, Jean-Louis B, Grange J (2004) Survival, anatomic and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (a 15 years experience with betarays). Am J Ophthalmol 137:893-900 10.1016/ j.ajo.2003.12.032
25. Salmon RJ, Levy C, Plancher C, Dorval T, Desjardins L, Leyvraz S, Pouillart P, Schlienger P, Servois V, Asselain B (1998) Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol 24:127-130 10.1016/S0748-7983(98)91485-8
26. Seddon JM, Albert DM, Lavin PT, Robinson N (1983) A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 101:1894-1899 6651594
27. Seregard S (1996) Posterior uveal melanoma. The Swedish perspective. Acta Ophthalmol Scand 74:315-329 8883543
28. Shammas HF, Blodi FC (1977) Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 95:63-69 836204
29. J Shields C Shields 1992 Introduction to melanocytic tumors of the uvea In: J Shields C Shields (eds.), Intraocular tumors; a text and atlas Williams & Wilkins Philadelphia, Pennsylvania
30. Singh AD, Wang MX, Donoso LA, Shields CL, Potter PD, Shields JA, Elston RC, Fijal B (1996) Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental? Arch Ophthalmol 114:1101-1104 8790096
31. L Sobin C Wittekind 2002 TNM classification of malignant tumours 6th edn. Wiley-Liss Genève
32. The Collaborative Ocular Melanoma Study (2001) Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 119:670-676
33. The Collaborative Ocular Melanoma Study Group (1997) Factors predictive of growth and treatment of small choroidal melanoma: COMS report no. 5. Arch Ophthalmol 115:1537-1544
34. Vidal JL, Bacin F, Albuisson E, Rozan R, Desjardins L, D'Hermies F, Grange JD, Chauvel P, Caujolle JP, Sahel J et al (1995) "Melanoma 92" Epidemiological study of uveal melanoma in France. J Fr Ophtalmol 18:520-528 7560797